1-(4-benzoylpiperazin-1-yl)-2-[6-(furan-2-yl)-4-methoxy-1H-indol-3-yl]ethane-1,2-dione
C26H23N3O5 — CID 127047390
Data last refreshed: (MolForge compound catalog, from PubChem)
About 1-(4-benzoylpiperazin-1-yl)-2-[6-(furan-2-yl)-4-methoxy-1H-indol-3-yl]ethane-1,2-dione
1-(4-benzoylpiperazin-1-yl)-2-[6-(furan-2-yl)-4-methoxy-1H-indol-3-yl]ethane-1,2-dione (PubChem CID 127047390) has the molecular formula C26H23N3O5 and a molecular weight of 457.49 g/mol. Its IUPAC name is 1-(4-benzoylpiperazin-1-yl)-2-[6-(furan-2-yl)-4-methoxy-1H-indol-3-yl]ethane-1,2-dione.
Molecular Properties
| Compound Name | 1-(4-benzoylpiperazin-1-yl)-2-[6-(furan-2-yl)-4-methoxy-1H-indol-3-yl]ethane-1,2-dione |
|---|---|
| PubChem CID | 127047390 |
| Molecular Formula | C26H23N3O5 |
| Molecular Weight | 457.49 g/mol |
| Exact Mass | 457.16 |
| IUPAC Name | 1-(4-benzoylpiperazin-1-yl)-2-[6-(furan-2-yl)-4-methoxy-1H-indol-3-yl]ethane-1,2-dione |
| SMILES | COc1cc(-c2ccco2)cc2[nH]cc(C(=O)C(=O)N3CCN(C(=O)c4ccccc4)CC3)c12 |
| InChI | InChI=1S/C26H23N3O5/c1-33-22-15-18(21-8-5-13-34-21)14-20-23(22)19(16-27-20)24(30)26(32)29-11-9-28(10-12-29)25(31)17-6-3-2-4-7-17/h2-8,13-16,27H,9-12H2,1H3 |
| InChIKey | GRMVZBHMTKEADK-UHFFFAOYSA-N |
| XLogP | 3.60 |
| TPSA | 95.85 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 34 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 457.49 |
| LogP ≤ 5 | 3.60 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 5 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'diketo_group', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 127047390 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.